We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




IR Spectroscopic Imaging Aids Diagnosis of Colon Cancer

By MedImaging International staff writers
Posted on 02 Sep 2019
Image: A new study asserts that FTIR chemical imaging can help identify colon cancer more accurately (Photo courtesy of ICL).
Image: A new study asserts that FTIR chemical imaging can help identify colon cancer more accurately (Photo courtesy of ICL).
Fourier-transform infrared (FTIR) spectroscopic imaging can produce 'chemical photographs' of biopsy tissue samples ranging from healthy to cancerous, according to a new study.

Researchers at Imperial College London (Imperial; United Kingdom) and the University of British Columbia (UBC; Vancouver, Canada) undertook FTIR spectroscopic imaging of colon biopsy tissues, combined it with a random forest machine learning (ML) approach in order to classify different stages of colon cancer malignancy. The combination of the optical and ML computational approaches helped eliminate scattering background during the measurements. The results demonstrated that C–H stretching and amide I bands are of little to no significance for the classification of colon malignancy.

The best prediction outcome was found when classification was carried out in the fingerprint region of the mid-infrared spectrum (7-10 micrometers; 1500- 1000 cm−1), which excludes the contribution of amide I and II bands. Overall prediction accuracy was higher than 90%, with dysplastic and hyperplastic tissues well distinguished. The study also showed that computational correction performed better than optical correction, and that disease states can be distinguished effectively even without elimination of scattering effects. The study was published on August 16, 2019, in Analytical and Bioanalytical Chemistry.

“There is urgency in developing new techniques which can identify the early stages of cancer in a way that goes beyond the current histopathology approaches in order to increase survival rates. Coupling spectroscopic imaging with advanced ML approaches aid early detection and understanding of cancer,” said senior author Professor Sergei Kazarian, PhD, of the ICL department of chemical engineering. “There is an excitement of having an enhanced accuracy that promises advances in the early cancer detection and differentiation of disease stages.”

FTIR imaging involves shining an infrared beam at a sample and measuring how much of that light is absorbed at different frequencies, which is used to produce a visual reference of the sample's chemical composition. And although the study was restricted to colon cancer, the researchers have already created models, which have the potential to be applied to other difficult to diagnose cancers such as esophageal cancer, and even non-cancerous anomalies.

Related Links:
Imperial College London
University of British Columbia

Ultrasound Table
Women’s Ultrasound EA Table
Digital Radiographic System
OMNERA 300M
Diagnostic Ultrasound System
DC-80A
Ultrasonic Pocket Doppler
SD1

Channels

Imaging IT

view channel
Image: Researchers develop a vision-language model trained on large-scale data to generate clinically relevant findings from chest computed tomography images through visual question answering (Ms. Maiko Nagao from Meijo University, Japan)

Interactive AI Tool Supports Explainable Lung Nodule Assessment

Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.